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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A150Figure 2. Primary human chondrocytes were pre-treated with inhibitors
for 30min and then treated with IL-1b/OSM overnight. Conditioned media
was immunoblotted for MMP-13. MMP-2 is shown as a loading control.
Experiment was repeated in 3 normal donors. Representative blots are
shown. PD98059: ERK inh. SP600125: JNK inh. SB203580: p38 inh. Rux-
olitinib: JAK1/2 inh.
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REDOX REGULATION OF CHONDROCYTE IGF-1 SIGNALING BY PKC-b1
V. Ulici y, D. Long z, R.F. Loeser, Jr. y. yUNC at Chapel Hill, Chapel Hill, NC,
USA; zWake Forrest Univ., Winston Salem, NC, USA
Purpose: Reactive oxygen species (ROS) can contribute to articular
cartilage degeneration in OA, but the mechanisms are incompletely
understood. IGF-1 signaling promotes chondrocyte matrix synthesis
and survival but is reduced in aging and OA. We have previously shown
that pathological levels of ROS activate chondrocyte MAP kinase sig-
naling and inhibit the IGF-1-IRS-1-PI3K-Akt pathway through phos-
phorylation of IRS-1 at inhibitory serine residues. In other tissues, PKC-
b1 activation by ROS was noted to serine phosphorylate IRS-1. In this
study, we investigated the role of PKC-b1 oxidation in regulating
chondrocyte IGF1 signaling under conditions of oxidative stress.
Methods: Primary human articular chondrocytes, isolated from normal
adult ankles, were treated for 30 mins. with 250mM tert-butyl hydro-
peroxide (tBHP) or 25mM menadione to induce oxidative stress. A PKC
general activator (PMA) and inhibitor (BIM) as well as a PKC-b speciﬁc
inhibitor (hispidin) were used to evaluate PKC regulation of IRS-1, ERK
MAP kinase and Akt phosphorylation, measured by immunoblotting.
PKC activation was measured by examining translocation from the
cytosol to the membrane by immunoblotting fractionated cell lysates.
PKC-b1 oxidation was evaluated by measuring cysteine sulfenic acid
formation using the reagent BCN-Bio1 which has a biotin tag allowing
for afﬁnity puriﬁcation of labelled proteins using streptavidin agarose
beads.
Results: Treatment of chondrocytes with PMA resulted in complete
inhibition of IGF1-induced phosphorylation of IRS-1 Tyr 612 (activating
site) as well as Akt phosphorylation and increased ERK and IRS-1 Ser
312 (inhibitory site) phosphorylation. The general PKC inhibitor BIM
blocked these effects conﬁrming they were due to PKC activation. ROS
induction using tBHP or menadione also activated ERK and decreased
IGF1 -induced IRS-1 Tyr 612 and p-Akt which was blocked by addition
of a PKC-b inhibitor. PKC-b1 translocated from the cytosol to the
membrane after treatment with menadione consistent with activation
by ROS (Fig.1A). A major mechanism for redox regulation of kinase
activity is through cysteine sulfenylation. We investigated this in
chondrocytes treated with menadione by afﬁnity labeling with BCN-
Bio1 which is speciﬁc for sulfenylation. PKC-b1 was pulled-down by
streptavidinwith the greatest amount seen after 30 mins. of menadione
treatment (Fig.1B).
Conclusions: These results support a role for PKC-b1 in the inhibition of
chondrocyte IGF-1 signaling under conditions of oxidative stress. Con-
sistent with our results, oxidation of PKC isoforms through cysteine
sulfenylation has been shown to promote their activity. Speciﬁc PKCs,
including PKC-b1, can serine phosphorylate IRS-1 resulting in inhibition
of downstream activation of Akt. Targeting the oxidative modiﬁcations
of PKC-b1 could serve as a novel means to restore the chondrocyte
response to IGF-1 in aging and OA.Fig.1. Oxidation of PKC-b1 in human chondrocytes treated with mena-
dione. (A) PKC-b1 translocation from the cytosol to the membrane. IGF-
1Rb (membrane) and LDH (cytosol) serve as fractionation controls. (B)
Pull-down of BCN-Bio1 tagged PKC-b1 using streptavidin. Levels of PKC-
b1 in the pre-pull down lysates shown as a control.
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SUPERFICIAL ZONE CHONDROCYTES SECRETE A FACTOR THAT
REGULATES DEEP ZONE CARTILAGE MINERALIZATION BY
MODULATING POLYPHOSPHATE LEVELS
E. Delve, S. Bromand, J.-P. St-Pierre, M. Grynpas, R. Kandel. The
Lunenfeld-Tanenbaum Res. Inst., Toronto, ON, Canada
Purpose: Articular cartilage is an avascular tissue with a complex
depth-dependent zonal architecture with unique matrix composition
and organization, vital for maintaining joint function. Osteoarthritis
(OA) is a degenerative disease that disrupts this zonal arrangement and
manifests initially as loss of the superﬁcial zone (SZ) followed by pro-
gressive matrix loss and advancement of the calciﬁed zone into the
remaining articular cartilage region. We have shown previously that
polyphosphate, a naturally occurring linear polymer of phosphates, can
regulate mineralization in articular cartilage. The hypothesis of this
study is that superﬁcial zone cells modulate calciﬁcation of deep zone
cartilage (DZ) by modulating levels of cartilage polyphosphate levels
through a soluble factor.
Methods: Articular chondrocytes were isolated from either the SZ or DZ
of bovine cartilage obtained from the metacarpal-phalangeal joints (6-9
months). The cells were seeded individually on 3Dmembrane inserts in
conditions that favour formation of cartilage tissue and grown in side-
by-side co-culture for up to 7 days in mineralization inducing media
(MIM, b glycerophosphate). As a control DZ cells were grown in co-
culture with DZ cells. To determine if SZ cells were producing a soluble
